Azimi, Alireza
Tuominen, Rainer
Costa Svedman, Fernanda
Caramuta, Stefano
Pernemalm, Maria
Frostvik Stolt, Marianne
Kanter, Lena
Kharaziha, Pedram
Lehtiö, Janne
Hertzman Johansson, Carolina
Höiom, Veronica
Hansson, Johan
Egyhazi Brage, Suzanne http://orcid.org/0000-0002-0524-2346
Article History
Received: 13 January 2017
Revised: 7 June 2017
Accepted: 19 June 2017
First Online: 31 August 2017
Competing interests
: Professor Johan Hansson has received personal fees for advisory boards from Roche, Bristol-Myers Squibb and Merck/MSD. Professor Janne Lehtiö has received grants from Astra Zeneca but not related to this melanoma project. The remaining authors declare no conflict of interest.